Bayer Denies Claim Made By Plaintiff In A Related Yaz Case

Bayer Denies Claim Made By Plaintiff In A Related Yaz Case

Introduction

A New Jersey State Appeals Court found loopholes in the expert report of a woman who blamed Bayer AG's Yaz and Yasmin birth control pills for her gallbladder disease. The pharmaceutical giant denied the claim made by the plaintiff to restore the litigation.

The lawsuits concerning Yaz related pulmonary embolism were the first to go for state court trial, followed by gallbladder injury cases and the final round would include blood clot injuries.

By May 2014, Bayer settled more than 8,200 lawsuits over pulmonary embolisms, heart attack and deep vein thrombosis (DVT), spending nearly $1.7 billion. As of May 2018, 63 Yaz and Yasmin lawsuits are pending in the multidistrict litigation (MDL No. 2100; In Re: Yasmin and Yaz Marketing, Sales Practices and Products Liability Litigation), which was formed in 2009 and is presided by Judge David R. Herndon in the Southern District of Illinois.